The National Hospital for Neurology & Neurosurgery

London WC1N 3BG

1 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease, MSA, NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO), Parkinson's Disease (PD), Progressive Multiple Sclerosis, Pure Autonomic Failure (PAF), Symptomatic Neurogenic Orthostatic Hypotension

Studies at this site

• Obe-cel in Refractory Progressive Forms of Multiple Sclerosis — Recruiting now
• Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) — Completed
• Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Stopped early
• A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease — Stopped early